1. Home
  2. HIPO vs JANX Comparison

HIPO vs JANX Comparison

Compare HIPO & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hippo Holdings Inc.

HIPO

Hippo Holdings Inc.

N/A

Current Price

$38.12

Market Cap

907.5M

Sector

Finance

ML Signal

N/A

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

N/A

Current Price

$17.20

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HIPO
JANX
Founded
2015
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
907.5M
1.0B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
HIPO
JANX
Price
$38.12
$17.20
Analyst Decision
Buy
Strong Buy
Analyst Count
5
18
Target Price
★ $40.88
$33.81
AVG Volume (30 Days)
208.9K
★ 680.4K
Earning Date
10-29-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 235.37
N/A
EPS
★ 0.65
N/A
Revenue
★ $468,600,000.00
$10,000,000.00
Revenue This Year
$24.25
$194.24
Revenue Next Year
$34.50
N/A
P/E Ratio
$59.20
★ N/A
Revenue Growth
★ 25.93
N/A
52 Week Low
$24.08
$12.12
52 Week High
$39.39
$35.34

Technical Indicators

Market Signals
Indicator
HIPO
JANX
Relative Strength Index (RSI) 76.14 50.40
Support Level $24.68 $15.83
Resistance Level N/A $19.16
Average True Range (ATR) 1.15 0.83
MACD 0.40 -0.03
Stochastic Oscillator 81.61 31.62

Price Performance

Historical Comparison
HIPO
JANX

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: